Director exercised or converted 7,718 GILD derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Aug 26, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Aug 27, 2026
DirectorOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001213307-26-000005
Added to OQROOct 2, 2026, 12:27 PM UTC Data qualityVerified: identifiers matched exactly IssuerGILEAD SCIENCES, INC. Reporting personAnthony Welters SecurityNon-qualified Stock Option (Right to Buy) TableDerivative (Table II) Transaction dateAug 26, 2026 Acquired / disposedDisposed (D) Footnotes from the filing
- The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026.
- 100% of the shares subject to the stock option vested immediately upon the grant date of October 22, 2020.
Around the same time
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Derivative exercise or conversion — not an open-market buy.